Changchun BCHT Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Changchun BCHT Biotechnology has a total shareholder equity of CN¥4.1B and total debt of CN¥65.4M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are CN¥5.1B and CN¥1.0B respectively. Changchun BCHT Biotechnology's EBIT is CN¥585.2M making its interest coverage ratio -49.8. It has cash and short-term investments of CN¥392.5M.
Key information
1.6%
Debt to equity ratio
CN¥65.40m
Debt
Interest coverage ratio | -49.8x |
Cash | CN¥392.48m |
Equity | CN¥4.08b |
Total liabilities | CN¥1.01b |
Total assets | CN¥5.09b |
Financial Position Analysis
Short Term Liabilities: 688276's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.0B).
Long Term Liabilities: 688276's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥10.7M).
Debt to Equity History and Analysis
Debt Level: 688276 has more cash than its total debt.
Reducing Debt: 688276's debt to equity ratio has reduced from 24.2% to 1.6% over the past 5 years.
Debt Coverage: 688276's debt is well covered by operating cash flow (385.1%).
Interest Coverage: 688276 earns more interest than it pays, so coverage of interest payments is not a concern.